Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Common deworming drug helps restore lung cancer's sensitivity to targeted therapy in mice

A form of lung cancer, which is found in about 10%–15% of Western patients and 40%–50% of Asian patients, is driven by a mutation in the epidermal growth factor receptor (EGFR) gene. Gefitinib is a go-to drug that shuts down this protein's signals. However, over time, cancer cells develop resistance to the drug and keep dividing even while treatment is underway, rendering gefitinib powerless. A…

Common deworming drug helps restore lung cancer's sensitivity to targeted therapy in mice

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Wednesday 14 October →